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Little more than 35 years ago, the notion that domineering 
mothers could induce schizophrenia in their children 
with their overbearing, identity-extinguishing behavior 
still held sway among psychiatrists. By the mid-1970s, the 
“schizophrenogenic”-mother hypothesis lost favor to genetic 
explanations of the disease. Researchers now believe that 
multiple genes interact with environmental factors, such as 
birth trauma or perinatal infection, to cause schizophrenia. 
And though defects in several chromosomes have been linked 
to schizophrenia, the hunt for candidate genes continues. 
Although the disease’s trademark delusions, hallucinations, 
social withdrawal, and emotional “ﬂattening” typically emerge 
in late adolescence or early adulthood, schizophrenia appears 
to be a developmental rather than a degenerative disorder. 
Evidence from human patients suggests that disrupted fatty 
acid metabolism may promote susceptibility, and efforts to 
understand how different drugs control schizophrenia’s 
symptoms have implicated several brain neurotransmitters, 
including dopamine, glutamate, and serotonin. Increasing 
evidence also suggests that defective glial cells—which not 
only support other brain cells but also control their activity—
may cause the disease.
In a new study, Akiko Watanabe et al. identify a candidate 
gene that links abnormal lipid metabolism to glial and 
developmental theories of schizophrenia. The gene, called 
Fabp7 (Fatty acid binding protein 7), encodes a protein that 
helps the essential fatty acid docosahexaenoic acid (DHA) 
assume its proper shape. It also has functional links to the 
glutamate receptor N-methyl-D-aspartic acid (NMDA). 
In schizophrenia, deﬁcits in the brain’s sensory “gating” 
mechanisms, which prevent sensory overload, disrupt a 
person’s ability to perceive or process information, leading 
in turn to abnormal thoughts (hearing voices) or actions 
(frenetic pacing or repetitive hand gestures). One such gating 
mechanism, called prepulse inhibition (PPI), can be studied 
by measuring the acoustic startle reﬂex in mice. In normal 
mice, PPI suppresses the startle reﬂex in response to an 
unexpected sound that is immediately preceded by a lower-
intensity sound. PPI, which is common in schizophrenia, serves 
as a measurable, internal biological marker for the disease. 
Researchers hope that identifying the genes responsible for 
PPI will point to genes that increase risk for schizophrenia.
Toward that end, Watanabe et al. screened four mouse 
strains for differences in their PPI responses. The researchers 
selected offspring of the two strains with the highest (the B6 
strain) and lowest (C3) responses for experimental testing 
and genetic analysis. Working with over 1,000 mice, they 
measured the amplitude and latency (delay between stimulus 
and maximum response) of the animals’ acoustic startle 
reﬂex and their PPI over a range of prepulse sound levels. 
To identify the gene variants (or alleles) that contribute 
to a complex, or quantitative, trait like schizophrenia (or its 
proxy, PPI), the researchers used quantitative trait loci (QTL) 
analysis, a statistical method that estimates the likelihood 
that speciﬁc loci (called quantitative loci) affect the trait (or 
phenotype) under study. The researchers collected genetic 
data from all 1,010 second-generation mice using 80 markers 
called “microsatellites,” short stretches of repeat DNA 
sequences with high mutation rates that provide a handy way 
of assigning individuals to different groups based on their 
microsatellite genotypes. They sorted mice into 21 groups 
with about 50 individuals each, and then measured their 
phenotypes (PPI at the different sound levels, acoustic startle 
reﬂex, and latency).
Using a computational model designed to detect QTL 
signals across the whole genome, the researchers identiﬁed 
six chromosomes with potential contributions to PPI, 
including a strong candidate on Chromosome 10. Next, 
they used a different computational model to extract more 
detailed information on the six chromosomes. They detected 
a very strong signal for PPI on the Chromosome 10 region 
that harbors the gene encoding the brain-type fatty acid 
binding protein (Fabp7). 
Fabp7 shows strong binding afﬁnity for the fatty acid 
DHA (disrupted DHA metabolism has been implicated 
in schizophrenia), and is required to maintain stem and 
progenitor cell populations in the developing rat cortex. It 
also participates in NMDA-mediated neuron signaling—which 
inﬂuences both PPI response and schizophrenia. Watanabe 
et al. used several experimental approaches to explore the 
gene’s functional link to PPI. 
First, they examined the gene’s transcript levels in the 
C3 and B6 mouse strains across different brain regions at 
discrete developmental time points: C3 animals (which had 
the lowest PPI response) had higher Fabp7 expression levels, 
with just a few exceptions (including the premature frontal 
cortex). By generating “knockout” mice with no functional 
Fabp7 proteins, they demonstrated a link between Fabp7 and 
reduced PPI and startle response latency. Young knockout 
mice also showed a marked reduction both in the number 
of embryonic stem and progenitor cells and in the number 
of proliferating cells, suggesting that Fabp7 disrupts new 
brain cell production. By performing what’s known as a 
“complementation test,” the researchers provided evidence 
for Fabp7 as one of the genes responsible for the PPI–QTL 
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Expression of Fabp7 protein in mouse brains at embryonic day 
16 (left) and postnatal day 0 (right). At both stages, Fabp7 is 
strongly expressed in the ventricular zone and radial glia, where 
neurogenesis is prominent.PLoS Biology  |  www.plosbiology.org 2442
signal on Chromosome 10. And when they analyzed tissue 
from the brains of deceased patients with schizophrenia and 
normal individuals, they found increased Fabp7 transcript 
levels in the affected tissue.
Taken together, these results indicate that Fabp7 is 
responsible for differences in the animals’ PPI responses and 
that the gene plays a vital role in brain development. Given 
the link between in utero malnutrition and increased risk for 
schizophrenia, the researchers reason that dysregulation of 
Fabp7 and lipid metabolism during development may cause 
long-term changes in gene expression, explaining an excess 
of Fabp7 in the schizophrenic cortex. Whether Fabp7 operates 
alone or with other genes on Chromosome 10 must be 
explored in future studies. And while no methods to prevent 
schizophrenia exist, the researchers recommend designing 
cohort studies to ﬁnd out whether supplementing the diets 
of pregnant mothers in high-risk families with DHA proves 
beneﬁcial.
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